Fimecs, Inc logo
VerifiedPharmaceutical Manufacturing· Founded 2018

Fimecs, Inc

FIMECS, Inc. is developing a new class of drugs based on targeted protein degradation for the currently ‘undruggable’ targets in immuno-oncology and oncology areas. The company became able to discover drug candidates for inducing the degradation of disease-relevant targeted proteins by integrating proprietary E3 ligase binders and RaPPIDS™ platform. This drug discovery platform will help providing drugs to the patients all over the world through various internal and collaboration projects.

7-day free trial · no credit card

HeadquartersXian, JapanEmployees13(11 to 50)Founded year2018Websitefimecs.comLinkedIn profileLinkedIn

Verified contacts

14

available on Kipplo

LinkedIn employees

13

11 to 50 range

Open roles

no listings

Distinct roles

10

indexed titles

Tech stack

1

tools in use

Monthly traffic

14

organic / mo

Sign up free to see all 14 verified contacts at Fimecs, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

14 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Fimecs, Inc

10 distinct titles indexed · top 10 shown.

  • 4principal scientist
  • 2chief executive officer
  • 1co-founder, chief executive officer
  • 1principal scientist (manager)
  • 1senior scientist
  • 1vice president of biology
  • 1vice president of r & d - oncology
  • 1ケミストリー
  • 1コーポレートディベロップメント バイスプレジデント
  • 1筑波大学大学院

Sign up to unlock all 14 contacts at Fimecs, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 14 verified contacts at Fimecs, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Fimecs, Inc | Kipplo Discover